What is Zacks Research’s Estimate for PBH Q2 Earnings?

Prestige Consumer Healthcare Inc. (NYSE:PBH) – Research analysts at Zacks Research decreased their Q2 2026 earnings estimates for shares of Prestige Consumer Healthcare in a research report issued on Thursday, October 16th. Zacks Research analyst Team now anticipates that the company will post earnings of $0.98 per share for the quarter, down from their previous forecast of $0.99. Zacks Research has a “Strong Sell” rating on the stock. The consensus estimate for Prestige Consumer Healthcare’s current full-year earnings is $4.50 per share. Zacks Research also issued estimates for Prestige Consumer Healthcare’s Q2 2027 earnings at $1.17 EPS, Q3 2027 earnings at $1.13 EPS and Q2 2028 earnings at $1.30 EPS.

Several other analysts also recently issued reports on the stock. Sidoti raised shares of Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and set a $80.00 price target on the stock in a research note on Wednesday, September 24th. Wall Street Zen downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Canaccord Genuity Group dropped their price target on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a “buy” rating on the stock in a research note on Friday, August 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Prestige Consumer Healthcare in a research note on Wednesday, October 8th. Finally, Oppenheimer dropped their price target on shares of Prestige Consumer Healthcare from $82.00 to $72.00 and set an “outperform” rating on the stock in a research note on Tuesday. Four research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $90.60.

Prestige Consumer Healthcare Price Performance

Shares of NYSE:PBH opened at $62.56 on Monday. The company’s fifty day moving average is $64.22 and its two-hundred day moving average is $75.01. The company has a quick ratio of 2.99, a current ratio of 4.38 and a debt-to-equity ratio of 0.55. Prestige Consumer Healthcare has a 12-month low of $60.15 and a 12-month high of $90.04. The company has a market cap of $3.08 billion, a P/E ratio of 14.69, a price-to-earnings-growth ratio of 1.97 and a beta of 0.44.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, August 7th. The company reported $0.95 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by ($0.06). Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The firm had revenue of $249.53 million for the quarter, compared to analyst estimates of $260.71 million. During the same period last year, the firm earned $0.90 earnings per share. Prestige Consumer Healthcare’s revenue for the quarter was down 6.6% compared to the same quarter last year. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS.

Institutional Investors Weigh In On Prestige Consumer Healthcare

A number of large investors have recently bought and sold shares of PBH. UMB Bank n.a. boosted its holdings in Prestige Consumer Healthcare by 81.8% in the second quarter. UMB Bank n.a. now owns 320 shares of the company’s stock worth $26,000 after purchasing an additional 144 shares in the last quarter. Caitong International Asset Management Co. Ltd boosted its holdings in Prestige Consumer Healthcare by 312.5% in the second quarter. Caitong International Asset Management Co. Ltd now owns 330 shares of the company’s stock worth $26,000 after purchasing an additional 250 shares in the last quarter. Maseco LLP bought a new stake in Prestige Consumer Healthcare in the second quarter worth $27,000. Elevation Point Wealth Partners LLC bought a new stake in Prestige Consumer Healthcare in the second quarter worth $46,000. Finally, First Horizon Advisors Inc. boosted its holdings in Prestige Consumer Healthcare by 294.1% in the second quarter. First Horizon Advisors Inc. now owns 599 shares of the company’s stock worth $48,000 after purchasing an additional 447 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.